4.45
-0.04 (-0.89%)
| Previous Close | 4.49 |
| Open | 4.47 |
| Volume | 764,354 |
| Avg. Volume (3M) | 1,481,218 |
| Market Cap | 1,707,064,320 |
| Price / Earnings (TTM) | 111.25 |
| Price / Earnings (Forward) | 10.45 |
| Price / Sales | 2.22 |
| Price / Book | 2.37 |
| 52 Weeks Range | |
| Earnings Date | 7 May 2025 |
| Profit Margin | 2.07% |
| Operating Margin (TTM) | 19.41% |
| Diluted EPS (TTM) | 0.040 |
| Quarterly Revenue Growth (YOY) | 1.00% |
| Quarterly Earnings Growth (YOY) | -88.60% |
| Total Debt/Equity (MRQ) | 74.99% |
| Current Ratio (MRQ) | 5.32 |
| Operating Cash Flow (TTM) | 183.89 M |
| Levered Free Cash Flow (TTM) | 116.77 M |
| Return on Assets (TTM) | 3.62% |
| Return on Equity (TTM) | 2.20% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | GoodRx Holdings, Inc. | Bearish | Bearish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | -2.5 |
| Technical Oscillators | -1.0 |
| Average | -0.50 |
|
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Core |
| % Held by Insiders | 11.56% |
| % Held by Institutions | 63.27% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Petrus Trust Company, Lta | 31 Dec 2024 | 2,950,089 |
| Rip Road Capital Partners Lp | 31 Dec 2024 | 2,408,577 |
| Technology Crossover Management X, Ltd. | 31 Dec 2024 | 1,653,566 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 8.00 (Wells Fargo, 79.78%) | Buy |
| Median | 6.75 (51.69%) | |
| Low | 5.50 (Truist Securities, 23.60%) | Hold |
| Average | 6.75 (51.69%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 4.65 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Truist Securities | 10 Apr 2025 | 5.50 (23.60%) | Hold | 4.32 |
| Wells Fargo | 28 Feb 2025 | 8.00 (79.78%) | Buy | 4.98 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 09 Apr 2025 | Announcement | GoodRx Announces Date for First Quarter 2025 Earnings Release and Conference Call |
| 03 Apr 2025 | Announcement | GoodRx Introduces New E-commerce Experience for Retail Pharmacies |
| 17 Mar 2025 | Announcement | GoodRx Appoints Aaron Crittenden as President of Rx Marketplace and Scott Pope, PharmD, as Chief Pharmacy Officer and Head of Clinical Engagement |
| 10 Mar 2025 | Announcement | GoodRx Report Reveals Striking Gender Divide in Prescription Medication Spending |
| 27 Feb 2025 | Announcement | GoodRx Reports Fourth Quarter and Full Year 2024 Results |
| 18 Feb 2025 | Announcement | GoodRx Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats |
| 05 Feb 2025 | Announcement | GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer |
| 30 Jan 2025 | Announcement | GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |